MannKind (MNKD)
(Delayed Data from NSDQ)
$5.82 USD
-0.07 (-1.19%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $5.82 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 221 - 228 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
A good day for MannKind: done with FDA meeting, successful Type 1 diabetes Phase III trial
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
It''s a CRL but no need for new studies, no safety issues raised: bear story loses a lot of its punch.
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S